Literature DB >> 8049500

The influence of storage on cytotoxic drug activity in an ATP-based chemosensitivity assay.

E M Hunter1, L A Sutherland, I A Cree, A M Subedi, D Hartmann, D Linder, P E Andreotti.   

Abstract

The use of viability assays to assess the effect of antineoplastic agents on cell lines and tumor cells is an important investigative tool and may have clinical relevance. Such assays require very small quantities of drugs and it is the practice of many laboratories to freeze aliquots of drugs for use in these assays as required. We have investigated the stability of 11 different agents in an ATP-based chemosensitivity assay which is being evaluated for clinical use. The results show that most drugs maintain their biological activity well when frozen at -20 degrees C for periods up to 24 months, or occasionally at room temperature. However, 4-hydroperoxycyclophosphamide and mitomycin C are exceptions to this rule, and should not be kept frozen for more than 2-3 months. Cisplatin is unstable when frozen and then thawed, but maintained activity at room temperature for at least 6 months. Since biological activity may not correlate completely with chemical stability, further studies on the effect of storage are required, but it seems unlikely that the appropriate use of frozen aliquots is a major source of error in tumor chemosensitivity assays.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8049500     DOI: 10.1097/00001813-199404000-00007

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  3 in total

1.  Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay.

Authors:  C M Kurbacher; I A Cree; U Brenne; H W Bruckner; J A Kurbacher; P Mallmann; P E Andreotti; D Krebs
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Cancer cell adaptation to chemotherapy.

Authors:  Federica Di Nicolantonio; Stuart J Mercer; Louise A Knight; Francis G Gabriel; Pauline A Whitehouse; Sanjay Sharma; Augusta Fernando; Sharon Glaysher; Silvana Di Palma; Penny Johnson; Shaw S Somers; Simon Toh; Bernie Higgins; Alan Lamont; Tim Gulliford; Jeremy Hurren; Constantinos Yiangou; Ian A Cree
Journal:  BMC Cancer       Date:  2005-07-18       Impact factor: 4.430

3.  Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C.

Authors:  P A Whitehouse; S J Mercer; L A Knight; F Di Nicolantonio; A O'Callaghan; I A Cree
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.